首页 > 最新文献

Journal of Clinical and Experimental Investigations最新文献

英文 中文
Myrtus Communis (Myrtle Tree: leaf and body) extract in Rat Renal Ischemia/Reperfusion injury 杨梅提取物对大鼠肾缺血/再灌注损伤的影响
Pub Date : 2022-08-29 DOI: 10.29333/jcei/12410
Hazen Saritas, H. Demirel, A. Bulbul, F. Gorucu, Zeynep Uğurlu, Yusuf Koc, I. Demirkan, Z. Saritaş
{"title":"Myrtus Communis (Myrtle Tree: leaf and body) extract in Rat Renal Ischemia/Reperfusion injury","authors":"Hazen Saritas, H. Demirel, A. Bulbul, F. Gorucu, Zeynep Uğurlu, Yusuf Koc, I. Demirkan, Z. Saritaş","doi":"10.29333/jcei/12410","DOIUrl":"https://doi.org/10.29333/jcei/12410","url":null,"abstract":"","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47265016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Luteinizing Hormone and Ovarian Stimulation for In-Vitro Fertilization: Do Science and Business Always Agree? 促黄体激素和卵巢刺激用于体外受精:科学和商业总是一致吗?
Pub Date : 2022-08-22 DOI: 10.31487/j.cei.2022.01.01
S. Kol, P. Humaidan
The current commentary paper follows the historical introduction of gonadotropins and gonadotropin releasing hormone (GnRH) analogues to the in-vitro fertilization (IVF) market. We maintain that business decisions significantly influenced research and development; however, pharma decisions did not always align with physiology and clinical interests. Specifically, the never-ending debate on the issue of luteinizing hormone (LH) supplementation during ovarian stimulation was repeatedly studied using population-based randomized controlled trials. However, LH activity supplementation is an endocrine issue and therefore, specific endocrine inclusion/exclusion criteria should be used when assessing the needs or not for LH in our “every-day” patients. We propose that the approach until now has defocused the research question and thus, also the debate and that there is a need to revisit physiology and clinical thinking if the LH supplementation issue is to be unravelled.
当前的评论论文遵循促性腺激素和促性腺激素释放激素(GnRH)类似物对体外受精(IVF)市场的历史介绍。我们认为,商业决策对研发有重大影响;然而,制药决策并不总是与生理学和临床利益一致。具体而言,在卵巢刺激期间补充黄体生成素(LH)的问题上永无止境的争论通过基于人群的随机对照试验反复研究。然而,黄体生成素活性补充是一个内分泌问题,因此,在评估“日常”患者是否需要黄体生成素时,应使用特定的内分泌纳入/排除标准。我们认为,到目前为止,这种方法已经分散了研究问题的焦点,因此,如果要解开LH补充问题,就需要重新审视生理学和临床思维。
{"title":"Luteinizing Hormone and Ovarian Stimulation for In-Vitro Fertilization: Do Science and Business Always Agree?","authors":"S. Kol, P. Humaidan","doi":"10.31487/j.cei.2022.01.01","DOIUrl":"https://doi.org/10.31487/j.cei.2022.01.01","url":null,"abstract":"The current commentary paper follows the historical introduction of gonadotropins and gonadotropin releasing hormone (GnRH) analogues to the in-vitro fertilization (IVF) market. We maintain that business decisions significantly influenced research and development; however, pharma decisions did not always align with physiology and clinical interests. Specifically, the never-ending debate on the issue of luteinizing hormone (LH) supplementation during ovarian stimulation was repeatedly studied using population-based randomized controlled trials. However, LH activity supplementation is an endocrine issue and therefore, specific endocrine inclusion/exclusion criteria should be used when assessing the needs or not for LH in our “every-day” patients. We propose that the approach until now has defocused the research question and thus, also the debate and that there is a need to revisit physiology and clinical thinking if the LH supplementation issue is to be unravelled.","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":"59 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74656359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monkeypox in Morocco: A perspective 摩洛哥的猴痘:一个视角
Pub Date : 2022-08-18 DOI: 10.29333/jcei/12375
Rachid Ait Addi, A. Benksim, F. E. Kasmaoui, M. Cherkaoui
{"title":"Monkeypox in Morocco: A perspective","authors":"Rachid Ait Addi, A. Benksim, F. E. Kasmaoui, M. Cherkaoui","doi":"10.29333/jcei/12375","DOIUrl":"https://doi.org/10.29333/jcei/12375","url":null,"abstract":"","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42587593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of polymorphisms in recurrent pregnancy loss: Factor V Leiden G1691A, Factor II G20210A, MTHFR C677T and Factor V H1299R 复发性妊娠丢失的多态性分析:因子V Leiden G1691A、因子II G20210A、MTHFR C677T和因子V H1299R
Pub Date : 2022-08-18 DOI: 10.29333/jcei/12373
M. Erdogan, Munevver Nisa Can, Cem Karaosmanoğlu, S. Yıldız, Mustafa Yildiz
{"title":"Analysis of polymorphisms in recurrent pregnancy loss: Factor V Leiden G1691A, Factor II G20210A, MTHFR C677T and Factor V H1299R","authors":"M. Erdogan, Munevver Nisa Can, Cem Karaosmanoğlu, S. Yıldız, Mustafa Yildiz","doi":"10.29333/jcei/12373","DOIUrl":"https://doi.org/10.29333/jcei/12373","url":null,"abstract":"","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41804110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In silico subtractive genomics approach characterizes a hypothetical protein (MG_476) from microplasma genitalium G37 在硅减基因组学方法表征了一个假设的蛋白质(MG_476)从微血浆生殖器G37
Pub Date : 2022-08-18 DOI: 10.29333/jcei/12377
Mohammad Mahfuz Ali Khan Shawan, Naznin Jahan, T. Ahamed, Arun Das, Md. Arif Khan, S. Hossain, S. Sarker
{"title":"In silico subtractive genomics approach characterizes a hypothetical protein (MG_476) from microplasma genitalium G37","authors":"Mohammad Mahfuz Ali Khan Shawan, Naznin Jahan, T. Ahamed, Arun Das, Md. Arif Khan, S. Hossain, S. Sarker","doi":"10.29333/jcei/12377","DOIUrl":"https://doi.org/10.29333/jcei/12377","url":null,"abstract":"","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45301058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of SARS-CoV-2 patients with annual RT-PCR analysis results SARS-CoV-2患者年度RT-PCR分析结果评价
Pub Date : 2022-08-18 DOI: 10.29333/jcei/12376
Yakup Artik, Selen Zeliha Mart Komurcu, N. Cesur, C. Kazezoğlu, Yasemin Tuba Sutasir
Background: Nowadays, people have faced with a pandemic called COVID-19. The reliable detection of the virus is important to prevent transmission of the virus. RT-PCR is a gold standard method for the diagnosis of the disease used at all over the world. The highest number of sample size (1,461,258 patient sample) and differing results are reported with our study regarding the PCR positivity rates. Method/Study Design: The study was aimed to evaluate the positivity and negativity of the patients with RT-PCR from all the samples studied between March 25, 2020 and March 25, 2021, when the pandemic was declared and started to be seen in Turkey, and to investigate its contribution to the total test capacity of our country. Results/Conclusions: 1,461,258 patient is observed, and this frequency male is 58% and female is 42% of the population. The maximum number of admissions is noticed during the Autumn-2020 involved age ranged from 25 to 35. 14.6% positive result is got while the 85.4% negative result is observed. When the age distribution of COVID-19 (+) patients is evaluated, COVID-19 (+) rate is highest in the 6-15 age range, followed by the 66-75 age range and the highest COVID-19 (+) rate are November and October, respectively. Additionally, the highest COVID-19 (+) rate is in Autumn. According to the test results, it was determined that 7.5% of the male participants were COVID-19 (+) and 7.1% of the female participants were COVID-19 (+).
背景:如今,人们面临着一场名为COVID-19的大流行。可靠的病毒检测对于防止病毒传播非常重要。RT-PCR是目前世界上广泛使用的诊断该疾病的金标准方法。我们的研究报告了最多的样本量(1,461,258例患者样本)和不同的PCR阳性率结果。方法/研究设计:本研究旨在评估2020年3月25日至2021年3月25日(土耳其宣布并开始观察到大流行)期间所有样本中RT-PCR患者的阳性和阴性,并调查其对我国总检测能力的贡献。结果/结论:共观察1461258例患者,其中男性占58%,女性占42%。在秋季至2020年期间注意到的最大入学人数涉及年龄在25至35岁之间。阳性结果为14.6%,阴性结果为85.4%。在评估COVID-19(+)患者的年龄分布时,6-15岁年龄段的COVID-19(+)率最高,其次是66-75岁年龄段,11月和10月的COVID-19(+)率最高。此外,COVID-19(+)率最高的是秋季。根据测试结果,确定7.5%的男性参与者为COVID-19(+), 7.1%的女性参与者为COVID-19(+)。
{"title":"Evaluation of SARS-CoV-2 patients with annual RT-PCR analysis results","authors":"Yakup Artik, Selen Zeliha Mart Komurcu, N. Cesur, C. Kazezoğlu, Yasemin Tuba Sutasir","doi":"10.29333/jcei/12376","DOIUrl":"https://doi.org/10.29333/jcei/12376","url":null,"abstract":"Background: Nowadays, people have faced with a pandemic called COVID-19. The reliable detection of the virus is important to prevent transmission of the virus. RT-PCR is a gold standard method for the diagnosis of the disease used at all over the world. The highest number of sample size (1,461,258 patient sample) and differing results are reported with our study regarding the PCR positivity rates. Method/Study Design: The study was aimed to evaluate the positivity and negativity of the patients with RT-PCR from all the samples studied between March 25, 2020 and March 25, 2021, when the pandemic was declared and started to be seen in Turkey, and to investigate its contribution to the total test capacity of our country. Results/Conclusions: 1,461,258 patient is observed, and this frequency male is 58% and female is 42% of the population. The maximum number of admissions is noticed during the Autumn-2020 involved age ranged from 25 to 35. 14.6% positive result is got while the 85.4% negative result is observed. When the age distribution of COVID-19 (+) patients is evaluated, COVID-19 (+) rate is highest in the 6-15 age range, followed by the 66-75 age range and the highest COVID-19 (+) rate are November and October, respectively. Additionally, the highest COVID-19 (+) rate is in Autumn. According to the test results, it was determined that 7.5% of the male participants were COVID-19 (+) and 7.1% of the female participants were COVID-19 (+).","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41832456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Multiple myeloma diagnosed by flow cytometry plotting of CD19-positive and negative plasma cells 流式细胞术检测cd19阳性和阴性浆细胞诊断多发性骨髓瘤
Pub Date : 2022-08-18 DOI: 10.29333/jcei/12374
M. Ohe, Koya Ito, H. Shida, K. Nagai, K. Furuya, T. Okamoto
{"title":"Multiple myeloma diagnosed by flow cytometry plotting of CD19-positive and negative plasma cells","authors":"M. Ohe, Koya Ito, H. Shida, K. Nagai, K. Furuya, T. Okamoto","doi":"10.29333/jcei/12374","DOIUrl":"https://doi.org/10.29333/jcei/12374","url":null,"abstract":"","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42224448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare but important cause of fever 一种罕见但重要的发热原因
Pub Date : 2022-08-16 DOI: 10.29333/jcei/12367
Y. Kajihara
{"title":"A rare but important cause of fever","authors":"Y. Kajihara","doi":"10.29333/jcei/12367","DOIUrl":"https://doi.org/10.29333/jcei/12367","url":null,"abstract":"","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42648565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nationwide restrictions to combat consecutive COVID-19 waves: Lessons learnt from a developing country like Bangladesh 全国范围内的限制措施应对连续的COVID-19浪潮:从孟加拉国等发展中国家吸取的经验教训
Pub Date : 2022-07-02 DOI: 10.29333/jcei/12207
Md. Faruque Miah, Aniqua Tasnim Chowdhury, S. Chowdhury, S. M. A. Sium, R. Reshad, S. Mim
Background: Since the first documentation of COVID-19, four waves have hit Bangladesh. This study provides an insight into the scenario of the country during each wave along with the regulations enforced to combat it and it will help the national policy makers to mitigate the loss during any future wave. Main body: Lockdowns were imposed in many phases but despite all these measures, people were reluctant to follow health guidelines, which worsened the situation. These extended restrictions hampered the country’s economy, people’s mental health, and the academic life of the students. To fight such a situation, alternative steps like stringent area-based lockdowns, imposing immediate restrictions, and ensuring compulsory quarantine for people coming from other countries can be taken. People need to be encouraged to follow health guidelines, wear masks, get vaccinated otherwise restrictions alone will not be enough to assist the country to overcome the loss during pandemic. Short conclusion: The identification of the transmitting path, as well as the conduct of contact tracing, must be constantly monitored. Strict legislation, along with people’s spontaneous inclination to obey health norms, can help the country overcome the epidemic and establish a positive outcome.
背景:自首次记录新冠肺炎以来,孟加拉国已遭受四波疫情。这项研究深入了解了该国在每一波浪潮中的情况,以及为应对这一浪潮而实施的法规,并将帮助国家政策制定者减轻未来任何浪潮中的损失。正文:封锁分多个阶段实施,但尽管采取了所有这些措施,人们仍不愿遵守健康指南,这使情况更加恶化。这些延长的限制阻碍了国家的经济、人民的心理健康和学生的学术生活。为了应对这种情况,可以采取其他措施,如严格的地区封锁、立即实施限制以及确保对来自其他国家的人进行强制隔离。需要鼓励人们遵守健康指南,戴口罩,接种疫苗,否则仅靠限制措施不足以帮助国家克服疫情期间的损失。简短结论:必须不断监测传播途径的识别以及接触者追踪的进行。严格的立法,加上人们自发地倾向于遵守卫生规范,可以帮助国家战胜疫情并取得积极成果。
{"title":"Nationwide restrictions to combat consecutive COVID-19 waves: Lessons learnt from a developing country like Bangladesh","authors":"Md. Faruque Miah, Aniqua Tasnim Chowdhury, S. Chowdhury, S. M. A. Sium, R. Reshad, S. Mim","doi":"10.29333/jcei/12207","DOIUrl":"https://doi.org/10.29333/jcei/12207","url":null,"abstract":"Background: Since the first documentation of COVID-19, four waves have hit Bangladesh. This study provides an insight into the scenario of the country during each wave along with the regulations enforced to combat it and it will help the national policy makers to mitigate the loss during any future wave. Main body: Lockdowns were imposed in many phases but despite all these measures, people were reluctant to follow health guidelines, which worsened the situation. These extended restrictions hampered the country’s economy, people’s mental health, and the academic life of the students. To fight such a situation, alternative steps like stringent area-based lockdowns, imposing immediate restrictions, and ensuring compulsory quarantine for people coming from other countries can be taken. People need to be encouraged to follow health guidelines, wear masks, get vaccinated otherwise restrictions alone will not be enough to assist the country to overcome the loss during pandemic. Short conclusion: The identification of the transmitting path, as well as the conduct of contact tracing, must be constantly monitored. Strict legislation, along with people’s spontaneous inclination to obey health norms, can help the country overcome the epidemic and establish a positive outcome.","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49157595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Piogenic liver abscess–A challenge for cooperation between family medicine and clinics 源性肝脓肿——家庭医学与临床合作的挑战
Pub Date : 2022-06-29 DOI: 10.29333/jcei/12190
T. Zavidić, Ema Dejhalla, David Zahirović, Đ. Lovrinić
{"title":"Piogenic liver abscess–A challenge for cooperation between family medicine and clinics","authors":"T. Zavidić, Ema Dejhalla, David Zahirović, Đ. Lovrinić","doi":"10.29333/jcei/12190","DOIUrl":"https://doi.org/10.29333/jcei/12190","url":null,"abstract":"","PeriodicalId":53255,"journal":{"name":"Journal of Clinical and Experimental Investigations","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44447920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical and Experimental Investigations
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1